To evaluate angiogenesis in patients with ccRCC, we sought to determine first whether a correlation exists between the tumor’s grade, VEGF-A positivity and MVD calculated by the CD34 labeling. The gene discussed is VEGFA; the disease is nonpapillary renal cell carcinoma.